Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cartesian Therapeutics Q1 2024 GAAP EPS $(10.50) May Not Be Comparable To $(0.89) Estimate, Sales $5.840M May Not Be Comparable To $1.250M Estimate

Author: Benzinga Newsdesk | May 08, 2024 07:22am

Posted In: RNAC